Skip to main content
Signal8

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc.

NYSE:XTNTHealthcare
-9.52%$0.2823
Mkt Cap$39.6M
Float62.62M
O/S140.29M
Inst Own57.2%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$39.60M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership57.24%

based on 140.29M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE American
CountryUSUS
IPO DateJul 1, 2010
Shares Outstanding140.29M
Float62.62M
Company Overview

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices.

The firm primarily serves orthopedic and neurological surgeons both within the United States and globally.

Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine.

Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system.

The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.

Leadership

Abhinav Jain

Director

John K. Bakewell

Director

Jonn R. Beeson

Director

Mark Schallenberger

Chief Operations Officer

Employees

151

Country

US

Sector

Healthcare

Website

xtantmedical.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
4
HOLD
1
SELL
0
TOTAL5
Insider Trading
InsiderTypeShares
Beeson Jonn R. profile photoBeeson Jonn R.Grant/Award215.5K
Lipschultz Tyler profile photoLipschultz TylerGrant/Award215.5K
BAKEWELL JOHN K profile photoBAKEWELL JOHN KGrant/Award215.5K
Browne Sean E profile photoBrowne Sean EGrant/Award550.0K
Browne Sean E profile photoBrowne Sean EAutomatic Sell10.6K
Neils Scott C profile photoNeils Scott CGrant/Award400.0K
Shareholders
57.2%
Institutional
(33)
11.3%
Insiderⓘ
(8)
5.5%
5%+ Owners
(1)
25.9%
Unattributed (incl. retail)ⓘ
Institutional57.2%
Insider11.3%
5%+ Beneficial5.5%
Unattributed (incl. retail)25.9%
Sources: 13F, Form 4, 13D/13GO/S: 140.3M · as of 7 Aug 2026 · SEC filings
Insiders & Institutional Holders
52-Week Range
$0.2702$0.9500
$0.2823(2nd percentile)
Volume
Average Daily Volume125.40K
85.66K today vs 125.40K avg(-32%)

30d Avg

125.40K

60d Avg

2.51M

90d Avg

1.72M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...